Search Results 51-60 of 16594 for HMB loading phase

  1. Phase I Dose Escalation Study for BAY 1251152 in Patients With Advanced Cancer - Mayo Clinic

    About this study. Determine the safety, tolerability, pharmacokinetics, maximum tolerated dose (MTD) and recommended phase 2 dose (RP2D) of BAY 1251152 in ...

  2. Phase 2/3 Study Of Efficacy And Safety Of THRV-1268 In Long QT Syndrome Type 2 (LQTS 2) - Mayo Clinic

    The purpose of this study is to evaluate the effect of oral THRV-1268 on QTcF interval by AUC method in participants with LQTS 2. Participation eligibility.

  3. RLY-2608-201-Ph2 Study Of RLY-2608 In PROS And PIK3CA Driven Malformations - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  4. Phase 2/3 Open-Label Trial Of Sibeprenlimab In The Treatment Of Immunoglobulin A Nephropathy - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  5. Phase Transitions: Ph.D. Students Explore Real-Time Seizure Detection and Antibiotic Resistance - News Archive

    In this article series, students who are at the end of Ph.D. training at Mayo Clinic Graduate School of Biomedical Sciences share their research experience.

  6. Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy - Mayo Clinic

    The secondary efficacy objective is to assess the effects of natalizumab versus placebo in drug-resistant focal epilepsy on additional measures of seizure ...

  7. A Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHD - Mayo Clinic

    The purpose of the study is to evaluate the safety and efficacy of GLASSIA as an add-on biopharmacotherapy to standard-of-care steroid treatment as the first- ...

  8. Treatment of Muscle Cramps in Patients with Liver Cirrhosis - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  9. A Study to Evaluate MEDI2228 in Subjects with Relapsed/ Refractory Multiple Myeloma - Mayo Clinic

    In the later phase (phase 3) ... There are also less common very early (phase 0) and later (phase 4) phases. ... load is undetectable by quantitative PCR.

  10. Phase 3 Study Of Taletrectinib Vs Placebo As An Adjuvant Therapy In ROS1 Positive NSCLC (TRUST-IV) - Mayo Clinic

    The purpose of this phase 3 multicenter double-blind randomized study is to assess the use of taletrectinib in the early-stage non-small cell lung cancer (NSCLC) ...